"The National Institutes of Health (NIH) is a tremendous resource for a new start-up, providing funding, expertise, materials, technologies, preclinical testing and access to clinical sites that would otherwise be difficult, if not impossible, for those on a limited budget to harness. This panel, including three NIH officials, will describe the main avenues of access to the following: SBIR/STTR, NIH-developed technologies and a wide range of research resources (such as data mining tools, clinical trial networks, toxicology testing). In addition, two biotech
industry representatives will provide views from the private sector on the benefits realized from working with the NIH."

Objective1:Educate the audience on how to compete successfully for awards and provide information on the new NIH Pipeline to Partnerships.

Objective2: Discuss novel technologies created at NIH "ripe for the picking" through licensing and/or research collaborations.

Objective3: Showcase the scientific resources available to the public.